Viewing Study NCT00394628



Ignite Creation Date: 2024-05-05 @ 5:08 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00394628
Status: UNKNOWN
Last Update Posted: 2007-05-30
First Post: 2006-10-31

Brief Title: AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Sponsor: Novacea
Organization: Novacea

Study Overview

Official Title: A Phase 1b2a Multicenter Open-Label Study of AQ4N in Combination With Radiation Therapy and Temozolomide to Evaluate the Safety Tolerability and Efficacy in Subjects With Newly Diagnosed Glioblastoma Multiforme
Status: UNKNOWN
Status Verified Date: 2007-05
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Phase 1b of the study will evaluate the safety and tolerability of AQ4N treatment at three different dose levels

Phase 2a of the study will further evaluate the safety tolerability and in addition efficacy of AQ4N treatment at a tolerated dose selected from Phase 1b
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None